Yorkshire-based dental firm, EthOss Regeneration Ltd, has rounded off its eighth consecutive year of growth.

The company, which is headquartered in Silsden, West Yorkshire, produces a groundbreaking dental product called ‘EthOss' - a material that encourages new bone growth during dental implant procedures.

Turnover has increased for an eighth consecutive year since the flagship product was launched in 2015, following the company's launch ten years ago by world-renowned dental implantologist Dr Peter Fairbairn and biomaterials expert Dr Paul Harrison.

The firm has also expanded its headcount to 13 during the 2022/23 financial year - a 30% increase - and invested in new product development and regulatory approvals around the globe, as well as hosting training and education events in locations including Hong Kong and New Zealand.

Already, EthOss operates in more than 65 countries worldwide, increasing its export markets by more than 60 percent over the last five years to include Australia, Germany, Italy, Saudi Arabia, South Africa and Sweden.

EthOss has also invested further its sustainability work this year, achieving ISO:14001 status in recognition of its environmental management systems, which include installing solar panels and an electric car charging point at its head office. And it's donated more than £15,000 to causes including the National Autistic Society, FareShare, Action Medic and Home-Start, and taken part in charitable events including Women V Cancer Ride the Night in Manchester throughout the year.

For further information about EthOss visit https://ethoss.dental/.